NewEdge Wealth’s Bio-Techne TECH Stock Holding History

NewEdge Wealth’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-16,233	Closed	-$814K	–	1062
2025 Q2	$814K	Buy	+16,233	New	+$816K	0.01%	582

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

NewEdge Wealth's TECH Position: Q3 2025 in Review

NewEdge Wealth sold out of Bio-Techne (TECH) in Q3 2025, closing a stake of 16,233 shares — an estimated $814K sold.

NewEdge Wealth first reported a position in TECH in Q2 2025 and held it in 1 quarter. The position peaked at $814K in Q2 2025. 576 funds tracked by Wall St. Rank hold TECH as of Q3 2025.

NewEdge Wealth reported no remaining Bio-Techne position as of Q3 2025 after selling out during the quarter.
NewEdge Wealth sold 16,233 Bio-Techne shares in Q3 2025, an estimated $814K.
NewEdge Wealth first reported a position in Bio-Techne in Q2 2025 and held it in 1 quarter.
NewEdge Wealth's Bio-Techne position peaked at $814K in Q2 2025.
576 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2025.

Based on NewEdge Wealth's 13F filing for Q3 2025, filed 7 Nov 2025.